2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected].

Developed in Collaboration With the American Association for Thoracic Surgery, Heart Failure Society of America, and Society of Thoracic Surgeons

[1]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[2]  Wojciech Zareba,et al.  ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[3]  H. Calkins,et al.  Erratum: HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies (Europace (2011) 13 (1077-1109) DOI: 10.1093/europace/eur245) , 2012 .

[4]  R. Lazzara,et al.  The Benefit of Cardiac Resynchronization Therapy and QRS Duration: A Meta‐Analysis , 2012, Journal of cardiovascular electrophysiology.

[5]  Nancy M Albert,et al.  Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee. , 2012, Journal of cardiac failure.

[6]  D. Rowland,et al.  Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. , 2012, American heart journal.

[7]  Jagmeet P. Singh,et al.  Biventricular pacing: current trends and future strategies. , 2012, European heart journal.

[8]  Philippe Mabo,et al.  A randomized trial of long-term remote monitoring of pacemaker recipients (The COMPAS trial) , 2011, European heart journal.

[9]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Soci , 2011, Journal of the American College of Cardiology.

[10]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[11]  Barry J Maron,et al.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, The Journal of thoracic and cardiovascular surgery.

[12]  David O. Martin,et al.  Predictors of response to cardiac resynchronization therapy in patients with a non-left bundle branch block morphology. , 2011, The American journal of cardiology.

[13]  M. Brignole,et al.  Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial. , 2011, European heart journal.

[14]  D. Rowland,et al.  Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. , 2011, Archives of internal medicine.

[15]  Jeroen J. Bax,et al.  Cardiac resynchronization therapy in paediatric and congenital heart disease patients. , 2011, European heart journal.

[16]  D. Simon,et al.  Effect of QRS Morphology on Clinical Event Reduction With Cardiac Resynchronization Therapy: Meta-Analysis of Randomized Controlled Trials , 2011 .

[17]  S. Saba,et al.  Predicting Hyperresponse Among Pacemaker‐Dependent Nonischemic Cardiomyopathy Patients Upgraded to Cardiac Resynchronization , 2011, Journal of cardiovascular electrophysiology.

[18]  H. Calkins,et al.  HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Heart rhythm.

[19]  W. Ghali,et al.  Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis. , 2011, Heart rhythm.

[20]  Paul J. Wang,et al.  Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). , 2011, Journal of the American College of Cardiology.

[21]  Wojciech Zareba,et al.  Left Ventricular Lead Position and Clinical Outcome in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) Trial , 2011, Circulation.

[22]  A. Boyle,et al.  The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. , 2011, Journal of the American College of Cardiology.

[23]  Finn Gustafsson,et al.  2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure , 2011 .

[24]  S. Greenfield,et al.  Clinical practice guidelines we can trust , 2011 .

[25]  Laura A. Levit,et al.  Finding what works in health care : standards for systematic reviews , 2011 .

[26]  John L Sapp,et al.  Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.

[27]  P. Heidenreich,et al.  Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up: The ALTITUDE Survival Study , 2010, Circulation.

[28]  R. Ariga,et al.  Greater Three‐Dimensional Ventricular Lead Tip Separation is Associated with Improved Outcome after Cardiac Resynchronization Therapy , 2010, Pacing and clinical electrophysiology : PACE.

[29]  Kevin Vernooy,et al.  Mechano-energetics of the asynchronous and resynchronized heart , 2010, Heart Failure Reviews.

[30]  Kenneth C Bilchick,et al.  Bundle-Branch Block Morphology and Other Predictors of Outcome After Cardiac Resynchronization Therapy in Medicare Patients , 2010, Circulation.

[31]  J Taylor,et al.  Focused update of the ESC Guidelines on device therapy in heart failure. , 2010, European heart journal.

[32]  M. Ackerman,et al.  Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience. , 2010, Heart rhythm.

[33]  J. Daubert,et al.  EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[34]  L. Jordaens,et al.  Who Are the Long-QT Syndrome Patients Who Receive an Implantable Cardioverter-Defibrillator and What Happens to Them?: Data From the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry , 2010, Circulation.

[35]  R. Schweikert,et al.  Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) Trial , 2010, Circulation.

[36]  Pier Giorgio Masci,et al.  Myocardial Structural, Perfusion, and Metabolic Correlates of Left Bundle Branch Block Mechanical Derangement in Patients With Dilated Cardiomyopathy: A Tagged Cardiac Magnetic Resonance and Positron Emission Tomography Study , 2010, Circulation. Cardiovascular imaging.

[37]  G. Annas,et al.  HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. , 2010, Heart rhythm.

[38]  David O. Martin,et al.  Cardiac Resynchronization Therapy in Non‐Left Bundle Branch Block Morphologies , 2009, Pacing and clinical electrophysiology : PACE.

[39]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[40]  Hongyan Qiao,et al.  Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers. , 2009, Journal of the American College of Cardiology.

[41]  M. Gold,et al.  Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. , 2009, Journal of the American College of Cardiology.

[42]  R. Sutton,et al.  Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices. , 2009, The American journal of cardiology.

[43]  S. Saba,et al.  Usefulness of baseline electrocardiographic QRS complex pattern to predict response to cardiac resynchronization. , 2009, The American journal of cardiology.

[44]  Stefano Ghio,et al.  Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. , 2008, Journal of the American College of Cardiology.

[45]  K. Ellenbogen,et al.  Benefit of Primary Prevention Implantable Cardioverter‐Defibrillators in the Setting of Chronic Kidney Disease: A Decision Model Analysis , 2008, Journal of cardiovascular electrophysiology.

[46]  J. Knuuti,et al.  Effects of CRT on myocardial innervation, perfusion and metabolism. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[47]  Jagmeet P. Singh,et al.  Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. , 2008, Journal of the American College of Cardiology.

[48]  J. Triedman.  Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenit , 2008, Circulation. Arrhythmia and electrophysiology.

[49]  S. Priori,et al.  HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. , 2008, Heart rhythm.

[50]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Journal of the American College of Cardiology.

[51]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.

[52]  J. Triedman,et al.  Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. , 2008, Journal of the American College of Cardiology.

[53]  L. Harris,et al.  Implantable Cardioverter-Defibrillators in Tetralogy of Fallot , 2008, Circulation.

[54]  P. Tchou,et al.  Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. , 2007, The New England journal of medicine.

[55]  M. Maleki,et al.  Prevalence of Mechanical Dyssynchrony in Heart Failure Patients with Different QRS Durations , 2007, Pacing and clinical electrophysiology : PACE.

[56]  Leslie Saxon,et al.  Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure , 2006, Circulation.

[57]  Catherine Klersy,et al.  Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. , 2006, Journal of the American College of Cardiology.

[58]  F. Prinzen,et al.  A new paradigm for physiologic ventricular pacing. , 2006, Journal of the American College of Cardiology.

[59]  S. Barold,et al.  Significance of QRS complex duration in patients with heart failure. , 2005, Journal of the American College of Cardiology.

[60]  E. Daoud,et al.  Left Ventricular‐Based Cardiac Stimulation Post AV Nodal Ablation Evaluation (The PAVE Study) , 2005, Journal of cardiovascular electrophysiology.

[61]  Arjun D. Sharma,et al.  Percent right ventricular pacing predicts outcomes in the DAVID trial. , 2005, Heart rhythm.

[62]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[63]  P. Vardas,et al.  Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation , 2005 .

[64]  Paul J. Wang,et al.  The Clinical Implications of Cumulative Right Ventricular Pacing in the Multicenter Automatic Defibrillator Trial II , 2005, Journal of cardiovascular electrophysiology.

[65]  J. Schroeder,et al.  Effects of Cardiac Resynchronization on Disease Progression in Patients With Left Ventricular Systolic Dysfunction, an Indication for an Implantable Cardioverter-Defibrillator, and Mildly Symptomatic Chronic Heart Failure , 2004, Circulation.

[66]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[67]  Jeroen J. Bax,et al.  Relationship Between QRS Duration and Left Ventricular Dyssynchrony in Patients with End‐Stage Heart Failure , 2004, Journal of cardiovascular electrophysiology.

[68]  K. Ellenbogen,et al.  Resynchronization Therapy for the Treatment of Heart Failure , 2003, Circulation.

[69]  S. Goodman,et al.  Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. , 2003, JAMA.

[70]  David O. Martin,et al.  Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. , 2002, JAMA.

[71]  Milton Packer,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[72]  Thomas Lavergne,et al.  Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. , 2002, Journal of the American College of Cardiology.

[73]  W. Braham,et al.  Cardiac Resynchronization in Chronic Heart Failure , 2002 .

[74]  J. Spinelli,et al.  Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. , 2001, Journal of the American College of Cardiology.

[75]  Thomas Lavergne,et al.  Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay , 2001 .

[76]  J. Blanc,et al.  Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. , 1997, Circulation.

[77]  H. Doval,et al.  Randomised trial of low-dose amiodarone in severe congestive heart failure , 1994, The Lancet.

[78]  A. Ahsan.  Indications for pacing , 1992, The Lancet.